Rare disease news

FDA approvals, research breakthroughs, clinical trials, and advocacy updates

Curated and summarized by AI for patients and caregivers

🔍
AllDrug approvalsClinical trialsResearchGrants & fundingAdvocacy & policyPipeline
Show:All newsBreaking onlyImportant & breaking
Date:7 days30 days90 daysAll time

1 article from the last 90 days matching "mjff"

ResearchRSSMay 8

MJFF renames study Parkinson’s Precision Medicine Initiative

The Michael J. Fox Foundation renamed its large Parkinson's disease study from the Parkinson's Progression Markers Initiative to the Parkinson's Precision Medicine Initiative. This name change shows how the study has evolved to focus on personalized medicine approaches. The study tracks Parkinson's patients over time to better understand the disease and find treatments tailored to individual patients.

WHY IT MATTERSIf you have Parkinson's disease, this study's shift toward precision medicine means researchers are working to identify which treatments will work best for your specific type of Parkinson's based on your individual characteristics.
Good to knowParkinson's disease

Get personalized rare disease news

Follow your conditions to see news about the diseases that matter to you — FDA approvals, trial openings, and research breakthroughs.

Create free account →Browse diseases